|
|
| (5 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| Commonly Used Drips with Concentrations
| | #REDIRECT[[Vasopressors]] |
| | |
| Medication
| |
| | |
| Indications
| |
| | |
| Concentration
| |
| | |
| StartRange
| |
| | |
| Maximum
| |
| | |
| Comments
| |
| | |
|
| |
| Amiodarone
| |
| | |
| SVT, UnstableVT, V-fib, Convert Afib to NSR
| |
| | |
| 900mg/500mL D5Ws (1.8mg/ml)
| |
| | |
| 150mg x10minà 1mg/min x6hrsà 0.5mg/min x18hr
| |
| | |
| 2.2 gm/day
| |
| | |
| Watch for ↓BP,worsened/new arrythmias
| |
| | |
|
| |
| Diltiazem
| |
| | |
| SVT, Afib/flutter
| |
| | |
| 125mg/125mL D5W (1mg/ml)
| |
| | |
| Load 0.25mg/kg à 5-15mg/hr
| |
| | |
| 15mg/hr x 24hrs
| |
| | |
| Monitor BP, HR, EKG, SVR
| |
| | |
|
| |
| Dobutamine
| |
| | |
|
| |
| | |
|
| |
| | |
| Refractory CHF, Cardiogenic Shock, use Dopamine first if BP low
| |
| | |
| 500 mg/250mL D5W (2mg/ml)
| |
| | |
| Initial 1
| |
| | |
| mcg/kg/min
| |
| | |
| à 2mcg/kg/min
| |
| | |
| 20 mcg/kg/min
| |
| | |
| monitor BP, EKG, UOP
| |
| | |
| Tachydysrhythmias
| |
| | |
| caution AMI, incr O2 req
| |
| | |
|
| |
| Dopamine
| |
| | |
| D>B>B/A>A
| |
| | |
| HypoTN p volume resus, cardiog shock, bradycard
| |
| | |
| 800 mg/250mL D5W
| |
| | |
| 1-5 mcg/kg/min (renal 0.5-2)
| |
| | |
| 20 mcg/kg/min
| |
| | |
| Monitor BP, EKG, UOP
| |
| | |
| tachydysrthm when d/c
| |
| | |
|
| |
| Epinephrine
| |
| | |
| VF or pulseless VT, Asystole, PEA, decr SVR
| |
| | |
| 8 mg/250mL D5W
| |
| | |
| 1-10 mcg/min
| |
| | |
| 20 mcg/min
| |
| | |
| Tachydysrhythmias
| |
| | |
| increase O2 demand
| |
| | |
|
| |
| Esmolol
| |
| | |
| Reduce VF in post MI, convert SVT/Afib/flut, decr AMI ischem
| |
| | |
| 2.5gm/250mL
| |
| | |
| NS
| |
| | |
| Load 500 mcg/kg x1min à 50 mcg/kg/min
| |
| | |
| 300 mcg/kg/min
| |
| | |
| Careful: bradycardia, AV block, dec BP, reactive airway, no mix c Ca Ch Blk
| |
| | |
|
| |
| Fentanyl
| |
| | |
| Sedation, pain
| |
| | |
| 1mg/100mL NS
| |
| | |
| 0.5-1mcg/kg/hr
| |
| | |
| 5 mcg/kg/hr
| |
| | |
| Resp depression
| |
| | |
|
| |
| Furosemide
| |
| | |
| Diuresis
| |
| | |
| 500mg/100mLD5
| |
| | |
| 10mg/hr
| |
| | |
| 100 mg/hr
| |
| | |
| Monitor UOP, Cr, lytes
| |
| | |
|
| |
| Insulin (reg)
| |
| | |
| BS control
| |
| | |
| 100units/100mL NS
| |
| | |
| Load 0.1units/kg à0.1-0.7units/hr
| |
| | |
| 10
| |
| | |
| units/hr
| |
| | |
| Use Insulin protocol form
| |
| | |
|
| |
| Labetalol
| |
| | |
| HTN urg/emerg
| |
| | |
| 200mg/300mL D5W
| |
| | |
| 2mg/min
| |
| | |
| 4mg/min
| |
| | |
| hypotension
| |
| | |
|
| |
| Midazolam
| |
| | |
| (Versed)
| |
| | |
| Sedation intubated pt
| |
| | |
| 100mg/100mL D5W
| |
| | |
| Load 10- 50 mcg/kgà20-100
| |
| | |
|
| |
| | |
| hypotension
| |
| | |
|
| |
| Neo-syneph (phenyleph)
| |
| | |
| Hypotension, vascular failure in shock, SVT
| |
| | |
| 80 mg/250mL D5W
| |
| | |
| Load 100 mcgà
| |
| | |
| 40-60 mcg/min
| |
| | |
| 200 mcg/min
| |
| | |
| Monitor BP, HR, SVR
| |
| | |
|
| |
| NTG
| |
| | |
| AMI and Ischemia/Infarction
| |
| | |
| 100 mg/250mL D5W
| |
| | |
| 0.1 mcg/kg/min
| |
| | |
| 5 mcg/kg/min
| |
| | |
| Hypotension, HA
| |
| | |
|
| |
| Nitroprussid
| |
| | |
| (Nipride)
| |
| | |
| Hypertensive crisis
| |
| | |
| Heart failure
| |
| | |
| 100 mg/250mL D5W
| |
| | |
| 0.5 mcg/kg/min
| |
| | |
| 10 mcg/kg/min
| |
| | |
| Watch BP, thiocynate tox, tinnitus, delirium, CP,vision
| |
| | |
|
| |
| Norepineph
| |
| | |
| (levophed)
| |
| | |
| Cardiogenic shock, Sig hypoTN w/ SBP <70
| |
| | |
| 8 mg/250mL D5W
| |
| | |
| 2 mcg/min
| |
| | |
| 20
| |
| | |
| mcg/min
| |
| | |
| Monitor BP, EKG, UO caution in AMI
| |
| | |
|
| |
| Octreotide
| |
| | |
| GI Bleed
| |
| | |
| 1250mcg/250mL D5W
| |
| | |
| 50 mcg bolus
| |
| | |
| à 25 mcg/hr
| |
| | |
| 50mcg/hr
| |
| | |
| Dysglycemia, bradycardia, hypothyroidism
| |
| | |
|
| |
| Protonix
| |
| | |
| GI Bleed
| |
| | |
|
| |
| | |
| 80mg bolus à 8mg/hr
| |
| | |
| 8mg/hr
| |
| | |
|
| |
| | |
|
| |
| Vasopressn
| |
| | |
| (Pitressin)
| |
| | |
| vasodilatory shock, pulseless VF/VT, DI, GIB
| |
| | |
| 100 units
| |
| | |
| /250mL D5W
| |
| | |
| 0.04 units/min
| |
| | |
| 1.0 unit/min
| |
| | |
| Inc SVR ++periph vasoconstr, bad in AMI; do not titrate for vasodilatory shock
| |
| | |
|
| |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
| | |
| | |
| | |
| [[Category:Drugs]] | |
